NVCR

$16.93+0.31 (+1.87%)

After Hours$16.93+0.00 (+0.00%)· Last close May 4

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally.

Overview Intraday ResearchPRO BacktestPRO Ask AIPRO TranscriptsPRO StatementsPRO

Intraday

Custom Range:

No data available for this range. Intraday data may be limited by the exchange.

Loading stock data…